Stephen A. Chan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Stephen A. Chan has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Kathryn M. Van Abel
Department of Otolaryngology–Head and Neck Surgery Mayo Clinic Rochester Minnesota USA
2 shared publications Daniel L. Price
Department of Otolaryngology—Head and Neck Surgery Mayo Clinic Rochester Minnesota USA
1 shared publicationDavid M. Routman
Department of Radiation Oncology Mayo Clinic Rochester Minnesota USA
1 shared publication- Emily E. Karp
Department of Otolaryngology-Head and Neck Surgery, Mayo Clinic Rochester, MN, USA
1 shared publication - Eric J. Moore
Department of Otolaryngology-Head and Neck Surgery, Mayo Clinic, Rochester, MN 55905, USA
1 shared publication Jan L. Kasperbauer
Department of Otolaryngology—Head and Neck Surgery Mayo Clinic Rochester Minnesota USA
1 shared publication
Latest Publications
- 6 August 2024
- Published by SAGE Publications in The Neuroradiology Journal
- Vol. 38 (3) , 377-381
Soft tissue aneurysmal bone cyst presenting as an enlarging neck mass: Case report and review of the head and neck literature
Soft tissue aneurysmal bone cysts (STABCs) are rare neoplasms histopathologically identical to aneurysmal bone cysts. These benign lesions are characterized by thin, peripheral ossification and no skeletal continuity. STABC may be difficult to distinguish from myositis ossificans (MO) and malignant entities from imaging and fine needle aspiration, due to rarity and overlapping features. We present a case of a STABC occurring in the paraspinal cervical muscles. The imaging, histopathology, molecular analysis, and treatment are discussed. Four other published cases of STABC of the head and neck are reviewed.
- 6 August 2024
- Published by SAGE Publications in The Neuroradiology Journal
- Vol. 38 (3) , 377-381
Soft tissue aneurysmal bone cyst presenting as an enlarging neck mass: Case report and review of the head and neck literature
Soft tissue aneurysmal bone cysts (STABCs) are rare neoplasms histopathologically identical to aneurysmal bone cysts. These benign lesions are characterized by thin, peripheral ossification and no skeletal continuity. STABC may be difficult to distinguish from myositis ossificans (MO) and malignant entities from imaging and fine needle aspiration, due to rarity and overlapping features. We present a case of a STABC occurring in the paraspinal cervical muscles. The imaging, histopathology, molecular analysis, and treatment are discussed. Four other published cases of STABC of the head and neck are reviewed.
- 1 May 2021
- Published by Wiley in Head & Neck
- Vol. 43 (9) , 2663-2671
Mucoepidermoid carcinoma of the parotid gland: Twenty‐year experience in treatment and outcomes
Background: Parotid gland mucoepidermoid carcinoma (MEC) has published five‐year cancer‐specific survival (CSS) rates of 77%–97%, with variance related to grade.Methods: Patients receiving primary surgery for parotid gland MEC from 1995 to 2014 at a tertiary medical center underwent clinical review, histopathologic review, and cytogenetic analysis. Survival outcomes were evaluated.Results: Among 58 patients, T/N/M classification was as follows: T1 in 35 patients, T2 in 14, T4a in 9, N0 in 53, N1 in 2, N2b in 3. Histologic grade was low in 27, intermediate in 17, and high in 12 patients with 98% MAML2 positivity. All patients underwent parotidectomy, and seven patients received adjuvant radiation therapy. CSS was 100% at 5 years and 94.1% at 10 and 15 years. Two patients experienced locoregional recurrence.Conclusions: Treatment with adequate surgical resection and adjuvant radiation therapy for high‐grade or advanced‐stage tumors yields excellent survival, independent of clinical stage or pathologic grade.
- 1 May 2021
- Published by Wiley in Head & Neck
- Vol. 43 (9) , 2663-2671
Mucoepidermoid carcinoma of the parotid gland: Twenty‐year experience in treatment and outcomes
Background: Parotid gland mucoepidermoid carcinoma (MEC) has published five‐year cancer‐specific survival (CSS) rates of 77%–97%, with variance related to grade.Methods: Patients receiving primary surgery for parotid gland MEC from 1995 to 2014 at a tertiary medical center underwent clinical review, histopathologic review, and cytogenetic analysis. Survival outcomes were evaluated.Results: Among 58 patients, T/N/M classification was as follows: T1 in 35 patients, T2 in 14, T4a in 9, N0 in 53, N1 in 2, N2b in 3. Histologic grade was low in 27, intermediate in 17, and high in 12 patients with 98% MAML2 positivity. All patients underwent parotidectomy, and seven patients received adjuvant radiation therapy. CSS was 100% at 5 years and 94.1% at 10 and 15 years. Two patients experienced locoregional recurrence.Conclusions: Treatment with adequate surgical resection and adjuvant radiation therapy for high‐grade or advanced‐stage tumors yields excellent survival, independent of clinical stage or pathologic grade.